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CORRESPONDENCEFig. 1. Shows a diagrammatic representation of some of the
possible exit sites. X marks the two spots found favourable in
our survey. Y marks the more traditional spot.Shoab and Aly on Campbell et al.
Our comments concern two points raised in the study
by Campbell and colleagues.1 Firstly, patient input is
important in the positioning of vascular access. In our
experience, the upper chest is the site preferred by
most patients in contrast to the findings of Campbell et
al. Secondly, it is suggested that many surgeons do not
offer patients choice regarding the site of implantation.
The placement of vascular access is often selected to
ensure that a long length of catheter is tunnelled and
that the exit site is at an anterior position. There is
evidence to suggest that a few centimetres of
tunnelling would suffice for the purpose of preventing
vessel site access infection.2 As suggested in the article
there were problems with the traditional placement
sites.
Many patients requiring vascular access are young
females. The older style placement of access devices
leads to difficulty in the wearing and placement of Bra
straps. Hickman’s lines have been placed just under
the breast or even in the area between the breasts.
Following feedback from patients and specialist
nursing staff we changed our practice at the Middlesex
hospital, London. We switched to using a shorter
tunnelling and exit site as shown in Fig. 1. We have
received positive feedback following changing the exit
site to the infra-clavicular position. We suggest that
shorter tunnelling with infra-clavicular exit is a totally
acceptable and in many instances a preferred mode of
placement of these lines. Campbell and colleagues
rightly suggest that problems are common for patients
with central lines in a variety of sites. In our
experience, the upper chest sites selected after
appropriate discussion with the patients were the
most acceptable. The exact exit site should be
discussed with every patient beforehand. The special-
ist nurse looking after the patient could effectively do
this.*Corresponding author. S.S. Shoab, Consultant Vascular and General
Surgeon, Ysbyty Gwynedd Hospital, Bangor, Gwynedd LL57 2PW,
UK.
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